UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (160) 160
carboplatin - administration & dosage (140) 140
paclitaxel - administration & dosage (139) 139
antineoplastic combined chemotherapy protocols - therapeutic use (133) 133
female (118) 118
middle aged (94) 94
aged (76) 76
lung neoplasms - drug therapy (65) 65
male (60) 60
adult (51) 51
drug administration schedule (47) 47
neoplasm staging (45) 45
cisplatin - administration & dosage (42) 42
lung neoplasms - pathology (41) 41
carcinoma, non-small-cell lung - drug therapy (40) 40
antineoplastic combined chemotherapy protocols - adverse effects (39) 39
ovarian neoplasms - drug therapy (36) 36
paclitaxel - adverse effects (33) 33
carboplatin - adverse effects (31) 31
combined modality therapy (31) 31
retrospective studies (25) 25
carboplatin (24) 24
survival rate (24) 24
life sciences & biomedicine (23) 23
paclitaxel (23) 23
science & technology (23) 23
oncology (22) 22
paclitaxel - therapeutic use (21) 21
carcinoma, non-small-cell lung - pathology (20) 20
chemotherapy (20) 20
disease-free survival (20) 20
adenocarcinoma - drug therapy (18) 18
carboplatin - therapeutic use (18) 18
antineoplastic agents, phytogenic - administration & dosage (17) 17
remission induction (17) 17
aged, 80 and over (16) 16
antineoplastic combined chemotherapy protocols - administration & dosage (16) 16
cancer (16) 16
chemotherapy, adjuvant (16) 16
deoxycytidine - analogs & derivatives (16) 16
antineoplastic agents - administration & dosage (15) 15
follow-up studies (15) 15
ovarian neoplasms - pathology (14) 14
ovarian neoplasms - surgery (14) 14
carboplatin/paclitaxel (13) 13
carcinoma, squamous cell - drug therapy (13) 13
deoxycytidine - administration & dosage (13) 13
quality of life (12) 12
treatment outcome (12) 12
etoposide - administration & dosage (11) 11
lung neoplasms - radiotherapy (11) 11
antineoplastic agents - therapeutic use (10) 10
carboplatin-paclitaxel (10) 10
endometrial neoplasms - drug therapy (10) 10
vinblastine - analogs & derivatives (10) 10
bevacizumab (9) 9
carcinoma, squamous cell - pathology (9) 9
lung neoplasms - secondary (9) 9
lung neoplasms - surgery (9) 9
ovarian cancer (9) 9
taxoids (9) 9
vinblastine - administration & dosage (9) 9
療法 (9) 9
antineoplastic agents - adverse effects (8) 8
cyclophosphamide - administration & dosage (8) 8
doxorubicin - administration & dosage (8) 8
endometrial neoplasms - pathology (8) 8
neoadjuvant therapy (8) 8
neoplasms. tumors. oncology. including cancer and carcinogens (8) 8
neutropenia - chemically induced (8) 8
taxoids - administration & dosage (8) 8
uterine cervical neoplasms - drug therapy (8) 8
antineoplastic agents, phytogenic - therapeutic use (7) 7
camptothecin - administration & dosage (7) 7
camptothecin - analogs & derivatives (7) 7
carcinoma, non-small-cell lung - radiotherapy (7) 7
chemoradiotherapy (7) 7
cisplatin - adverse effects (7) 7
fluorouracil - administration & dosage (7) 7
hematology, oncology and palliative medicine (7) 7
leukopenia - chemically induced (7) 7
lung neoplasms - therapy (7) 7
lymph node excision (7) 7
neoplasm recurrence, local - drug therapy (7) 7
paclitaxel - analogs & derivatives (7) 7
peritoneal neoplasms - drug therapy (7) 7
tomography, x-ray computed (7) 7
カルボプラチン (7) 7
併用 (7) 7
進行 (7) 7
adenocarcinoma - pathology (6) 6
brain neoplasms - secondary (6) 6
breast neoplasms - drug therapy (6) 6
cancer therapies (6) 6
care and treatment (6) 6
disease progression (6) 6
gefitinib (6) 6
lymphatic metastasis (6) 6
neoplasm recurrence, local (6) 6
non-small cell lung cancer (6) 6
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
Japanese (120) 120
Chinese (39) 39
English (35) 35
German (1) 1
Italian (1) 1
Korean (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Supportive care in cancer, ISSN 0941-4355, 3/2016, Volume 24, Issue 3, pp. 1241 - 1249
Journal Article
Cancers, ISSN 2072-6694, 10/2020, Volume 12, Issue 11, p. 3110
BACKGROUNDPlatinum-based chemotherapy with cetuximab is the standard of care for relapsed or metastatic squamous cell carcinoma of the head and neck (SCCHN).... 
relapsed/metastatic SCCHN | first-line therapy | cetuximab | carboplatin/paclitaxel | cisplatin/5-FU
Journal Article
Clinical oncology (Royal College of Radiologists (Great Britain)), ISSN 0936-6555, 02/2020, Volume 32, Issue 2, pp. 121 - 130
Although cisplatin–fluoropyrimidine-based definitive chemoradiotherapy (dCRT) is a standard of care for oesophageal cancer, toxicity is significant and limits... 
definitive chemoradiotherapy | Carboplatin–paclitaxel | oesophageal cancer | UK multicentre | Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus
Journal Article
Critical reviews in oncology/hematology, ISSN 1040-8428, 09/2020, Volume 153, pp. 103035 - 103035
•Treatment switching and immature data determinants for difference median and mean.•Mean survival larger than the median due to persistent survival... 
Targeted therapies | Survival analysis | Overall survival | Non-small cell lung cancer | Immunotherapies | CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | COMPARING GEFITINIB | ADENOCARCINOMA | OPEN-LABEL | DOCETAXEL | CHEMOTHERAPY | TRIAL | RANDOMIZED PHASE-III | ERLOTINIB | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Index Medicus
Journal Article
Lung cancer (Amsterdam, Netherlands), ISSN 0169-5002, 2015, Volume 88, Issue 2, pp. 181 - 186
Journal Article
Journal Article
Journal Article
Journal Article
Current cancer therapy reviews, ISSN 1573-3947, 02/2006, Volume 2, Issue 1, pp. 81 - 99
Journal Article
Radiation oncology (London, England), ISSN 1748-717X, 08/2018, Volume 13, Issue 1, pp. 139 - 139
Background: While neoadjuvant chemoradiation therapy (nCRT) with subsequent surgery is the treatment of choice for patients with locally advanced or... 
Squamous cell carcinoma of the esophagus | Carboplatin/paclitaxel | Cisplatin/5-fluoruracil | Definite chemoradiation | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Chemoradiotherapy - adverse effects | Chemoradiotherapy - methods | Prospective Studies | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Neoplasm Recurrence, Local | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Male | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Female | Aged | Retrospective Studies | Body Surface Area | Esophageal Neoplasms - therapy | Paclitaxel - administration & dosage | Usage | Care and treatment | Patient outcomes | Adjuvant treatment | Research | Radiotherapy | Methods | Esophageal cancer | Cancer | Toxicity | Radiation | Clinical trials | Multivariate analysis | Cancer therapies | Motivation | Surgery | Older people | Paclitaxel | Dosimetry | Age | Evaluation | Squamous cell carcinoma | Histology | Radiation therapy | Regression analysis | Patients | Cisplatin | Radiation dosage | Esophagus | Chemotherapy | Carboplatin | Taxation | Health risk assessment | Surface area | Geriatrics | Index Medicus
Journal Article
Journal for immunotherapy of cancer, ISSN 2051-1426, 05/2019, Volume 7, Issue 1, pp. 122 - 122
Journal Article